Endocrine Therapy and Targeted Agents for Early-Stage HR+ Breast Cancer
William J. Gradishar, MD, FACP
Renal Cell Carcinoma (RCC): Current Approach to First Line Therapy and Beyond
Petros Grivas, MD, PhD
Liquid Biopsy: Advances in the Last Decade and Future Directions
Edgardo S. Santos Castillero, MD, FACP
Seven Years of Biosimilar Experience in the U.S., Where Untapped Value Remains
Jorge J. García, PharmD, MS, MHA, MBA, FACHE
Integrative Oncology: Treatment Approaches for Stress in Cancer Patients and Survivors
Ashwin Mehta, MD, MPH
